Naprosyn (Naproxen)

Naproxen, the active ingredient in Naprosyn, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It is used to relieve mild to moderate pain, reduce inflammation in arthritis, and manage gout flares. GNH USA supplies Naprosyn as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naprosyn belongs to the NSAID class and is indicated for several inflammatory and pain‑related conditions. - Mild to moderate pain: provides symptomatic relief of aches and discomfort. - Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility. - Osteoarthritis: alleviates chronic joint discomfort and stiffness. - Dysmenorrhea: eases menstrual‑related cramping and pain. - Gout flares: helps control acute gout pain and swelling.

Adverse reactions may occur with naproxen therapy and are categorized by frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo: transient sensations of imbalance.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration: may present as black stools or vomiting blood. - Cardiovascular events: increased risk of myocardial infarction or stroke, especially with long‑term use. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before using Naprosyn, consider the following safety measures. - Assess renal function: monitor kidney health, especially in patients with pre‑existing impairment. - Evaluate cardiovascular risk: use cautiously in individuals with heart disease or hypertension. - Review gastrointestinal history: avoid in patients with active ulcers or a history of serious GI bleeding. - Check for drug allergies: discontinue if hypersensitivity to naproxen or other NSAIDs occurs. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Naproxen may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors: additive cardiovascular and gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors, diuretics): may reduce blood‑pressure‑lowering effect. - Lithium: naproxen can raise lithium serum levels, risking toxicity. - Methotrexate: may increase methotrexate concentrations and toxicity.